A sister injects COVISHIELD vaccine into a patients body during vaccination.With urgent effect , COVID vaccination drives starts in India from 16th of January 2021.The vaccination progrmae are allotted exclusive to the frontline health workers in its first phase of vaccine drive. As of now, COVISHIELD and COVAXIN has been approved by Indian government for use for vaccination. Kolkata India - ZUMAc211 20210116_zip_c211_008

A sister injects COVISHIELD vaccine into a patients body during vaccination.With urgent effect , COVID vaccination drives starts in India from 16th of January 2021.The vaccination progrmae are allotted exclusive to the frontline health workers in its first phase of vaccine drive. As of now, COVISHIELD and COVAXIN has been approved by Indian government for use for vaccination. Kolkata India - ZUMAc211 20210116_zip_c211_008

Choose your license

Rights Managed:

One-time editorial use in an online article, social media channels, internal presentation, website, newsletter, or blog.

One-time editorial use in a book, newspaper or magazine (excluding cover page), external presentation. Limited to 5,000 circulation. This includes the rights available in the Standard license.

Media Info

Credit: ZUMA Press Wire

Media ID:

Recording Date: Jan 16, 2021

Media Size: 4,904×3,269 Pixels

January 16, 2021, Kolkata, West Bengal, India: A sister injects COVISHIELD vaccine into a patients body during vaccination.With urgent effect , COVID vaccination drives starts in India from 16th of January 2021.The vaccination progrmae are allotted exclusive to the frontline health workers in its first phase of vaccine drive. As of now, COVISHIELD and COVAXIN has been approved by Indian government for use for vaccination. Kolkata India - ZUMAc211 20210116_zip_c211_008

Release Info: Do I need a release?

Captions may have been translated or enriched by an AI system.
For more information about AI-assisted captions, see AI-assisted captions.

Need a custom license?

If your intended use isn't covered by the available options (such as non-editorial purposes or specific distribution needs), contact us. Our team will be happy to provide a tailored offer based on your requirements.